ESTRO 2026

Upright Meets Adaptive: Leo Cancer Care and RaySearch To Elevate Precision Radiation Therapy

May 14, 2026

Upright Meets Adaptive: Leo Cancer Care and RaySearch To Elevate Precision Radiation Therapy

New collaboration integrates upright patient positioning with real-time adaptive planning to improve precision, efficiency, and patient experience. 

Leo Cancer Care, a pioneer in upright radiation therapy solutions, today announced an expanded partnership with RaySearch Laboratories to bring online adaptive radiation therapy (oART) capabilities to upright treatment workflows across its future technologies, including Grace and its particle therapy solution. 

Building on a shared vision to transform cancer care, the collaboration will integrate Leo Cancer Care’s upright patient positioning technology with RayStation® and RayCare®, enabling clinicians to adapt treatment plans in real time based on daily anatomical changes, while patients remain in a natural, seated position. 

Online adaptive radiation therapy represents a major step forward in precision oncology, allowing clinicians to treat with a plan based on the anatomy of the day rather than, in some cases, weeks old. By extending these capabilities to upright workflows, Leo Cancer Care and RaySearch aim to unlock new levels of accuracy, comfort, and clinical efficiencies. 

The integration will support: 

  • Online plan adaptation using advanced imaging and AI-driven tools  
  • Improved targeting accuracy through natural organ positioning in upright posture  
  • Enhanced patient comfort and stability, particularly for lung and thoracic indications  
  • Streamlined clinical workflows via seamless software-hardware integration 

“This partnership marks a significant milestone in making adaptive radiation therapy more accessible and effective,” said Niek Schreuder, Chief Scientific Officer for Leo Cancer Care. “By combining upright positioning with RaySearch’s powerful adaptive planning capabilities, we are redefining what’s possible in patient-centric cancer treatment.” 

The fast automated replanning workflow in RayStation® will guide clinicians through tools for: 

  • Automatic organ segmentation 
  • Re-computation of the plan on the daily CT 
  • Re-optimisation of the plan on the daily CT 
  • Decision support for choosing to use the adapted or the original plan and transferring the plan seamlessly into RayCare® 

Erik Engwall, Chief Physicist and Head of Physics from RaySearch added: “Integrating online adaptive therapy into upright treatment environments opens new opportunities to increase precision. Together with Leo Cancer Care, we are enabling clinicians to respond to changes in patient anatomy during treatment, without compromising workflow efficiency.” 

The expanded partnership reflects both companies’ commitment to innovation in radiation oncology. Leo Cancer Care’s upright solutions, designed to improve patient experience and anatomical reproducibility, pair perfectly with RaySearch’s leadership in adaptive software. 

By enabling online adaptive workflows in a seated position, the collaboration aims to: 

  • Increase access to advanced adaptive treatments  
  • Reduce margins and spare healthy tissue  
  • Support more efficient use of clinical resources 

Make sure to find out more if you are attending ESTRO 2026 in Stockholm, Sweden, by visiting Leo Cancer Care at booth C11:31 and RaySearch at booth C14:45. 

Please note

Certain features and workflows described are subject to regulatory clearance and may not be available for sale or clinical use in all markets. 

Online Adaptive radiotherapy functionality and associated integrated upright treatment workflows are not cleared or approved for sale or clinical use in the United States or Canada. Availability in other markets is subject to applicable regulatory approvals and varies by region. 

Leo Cancer Care’s Grace™ solution is currently under development and is not cleared or approved for sale. Leo Cancer Care’s Marie® solution is currently commercially available only in the United States, having received 510(k) clearance.

FIND OUT MORE ABOUT OUR ESTRO ACTIVITIES

Subscribe to our newsletter

STAY CONNECTED

Get the latest updates and exclusive offers delivered straight to your inbox

Subscribe
Skip to toolbar